Abstract
The Clinical Bundle includes the following reports:
- Clinical Chemistry Analyzers.
- Clinical Immunoanalyzer Markets.
- Clinical Laboratory Testing Volume 1: Reagents and Instruments.
- Clinical Laboratory Testing Volume 2: Business Strategies.
Clinical Chemistry Analyzers
Clinical chemistry analysis is one of the most important areas within clinical
laboratory analysis. The term clinical chemistry usually refers to determining
the concentration or activity of a protein, carbohydrate, lipid, electrolyte,
enzyme or small molecule in easily-collected bodily fluids such as blood,
serum, plasma or urine. However, it is not necessarily limited to these
determinations. The analysis of virtually any biologically-active
substance-any place in the body-can loosely be defined as clinical chemistry.
In fact, traditional specialization barriers such as microbiology, hematology,
blood banking, immunology and even anatomical pathology are rapidly fading,
both operationally and instrumentally. But for the sake of defining the
subject to a reasonable size, the more traditional scope of clinical chemistry
will be the subject of this TriMark Publications study. The purpose of this
report is to describe the specific segments of the global clinical chemistry
instrumentation market. Specifically, this study examines the markets for
small lab and highly-automated, large lab platforms, as well as accessory
equipment such as reagents, supplies and manufacturers' original equipment
manufacturer (OEM) additional equipment. The emphasis is on those companies
and products that are actively developing and marketing chemistry analyzer
products for the clinical setting, including hospitals, independent labs,
physician' s offices and clinics. Concentration is on the clinical chemistry
instrumentation industry market segment in the U.S. and around the world.
Particular attention is paid to those areas of the clinical chemistry
instrumentation sector that are showing the greatest growth or the most
innovation.
Clinical Immunoanalyzer Markets
Clinical immunoanalyzer analysis is one of the most important functions of
clinical laboratory analysis. By all accounts, automated immunoassay testing
is the most rapidly developing of the traditional clinical laboratory sectors.
Clinical immunoanalyzer analysis usually refers to determining the
concentration or activity of protein, carbohydrate, lipid, enzyme or small
molecule in easily collected body fluids, such as blood, serum, plasma or
urine. However, it is not necessarily limited to these purposes. The analysis
of virtually any biologically active substance in any place in the body can
generally be defined as clinical immunoassay testing. In fact, traditional
specialization barriers, such as microbiology, hematology, blood banking,
immunology and even anatomical pathology are fading rapidly, both
operationally and instrumentally. This TriMark Publications report deals with
the traditional scope of clinical immunoassay, while looking at the emerging
technology trends in this sector. The purpose of this study is to describe the
specific segments of the global clinical immunoanalyzer instrumentation
market. Within this area, the highly-active segments in terms of innovation
and growth are covered. Specifically, it examines the markets for small labs
and highly-automated large lab platforms, as well as the market for accessory
equipment, such as reagents and supplies. Emphasis is on those companies and
products that are actively developing and marketing immunoanalyzer products
for clinical setting, including hospitals, independent labs, physician' s
offices and clinics.
Clinical Laboratory Testing Volume 1: Reagents and Instruments
Clinical laboratory analysis for in vitro diagnostic (IVD) testing is one of
the most important sectors of medical care. By all accounts, it is very
mature, large and diverse-crossing the $33 billion mark in 2006-and employing
over 100,000 laboratory workers, and spawning an industry for reagents and
instruments comprised of thousands of companies worldwide. The term clinical
laboratory analysis usually refers to determining the concentration or
activity of a protein, carbohydrate, lipid, electrolyte, enzyme or small
molecule in easily collected body fluids such as blood, serum, plasma or
urine. However, it is not necessarily limited to these determinations. The
purpose of this TriMark Publications report is to describe the specific
segments of the global clinical laboratory instrumentation and reagent market.
Within this area, the report covers those segments that are highly active in
terms of innovation and growth. Specifically, this global clinical laboratory
markets report examines the markets for small lab equipment all the way up to
highly-automated, large lab platforms, as well as accessory equipment such as
reagents, supplies and manufacturers' original equipment manufacturer (OEM)
additional equipment. The emphasis in this analysis is on those companies and
products that are actively developing and marketing laboratory analyzer
products for the clinical setting, including hospitals, independent labs,
physician' s offices and miscellaneous clinics. This study concentrates on the
clinical laboratory instrumentation industry market segment and the companion
reagents sector in the U.S. and around the world. The regional markets and
their differences are examined, including Europe, Asia (Japan, China and
India) and the rest of the world (ROW). Particular attention is paid to those
areas of the clinical laboratory instrumentation and reagents sector that are
showing the greatest growth or the most innovation.
Clinical Laboratory Testing Volume 2: Business Strategies
Clinical laboratory testing is generally categorized as either of two general
areas-clinical testing and anatomical pathology testing. Clinical and
anatomical pathology procedures are frequently ordered as part of regular
physician office visits and hospital admissions in connection with the
diagnosis and treatment of illnesses. As such, clinical laboratory analysis is
one of the most important sections of medical care. The purpose of this
TriMark Publications report is to describe the specific segments of the
clinical laboratory analysis business. The emphasis in this review is on those
companies that are actively developing and marketing laboratory data for the
clinical setting, including hospitals, independent labs, physician' s offices
and miscellaneous clinics. This study concentrates on the clinical laboratory
industry in the U.S. It defines the dollar volume of sales in each major
market and analyzes the factors that influence the size and the growth of the
individual market segments. The study surveys some of the primary companies
known to be marketing clinical laboratory data into the market. Each company
is discussed in depth with a section on the history of the company, the
product line, business and marketing analysis, and a subjective commentary of
the position of the company in its market.
|
Related Report
|